Back to all announcements

DJ Valiant Investments Plc GM Result, inter alia Change of Name, Board, Strategy

 
TIDMVALP 
 
24 June 2019 
 
                            VALIANT INVESTMENTS PLC 
                  (To be renamed Eurocann International plc) 
                                (the "Company") 
 
        Result of GM and inter alia Change of Name, Board and Strategy 
 
The Company (NEX: BUD) is pleased to announce that at the General Meeting of 
Shareholders held on Friday 21 June 2019, all resolutions were duly passed. 
 
A copy of the Circular is available at:  http://www.valiantinvestments.co.uk/ 
 
Jeremy Ross and Burns Singh Tennent-Bhohi will now join the board of directors 
alongside Conrad Windham, whilst Edward Taylor has today stepped down from the 
Board. Edward will continue to act as the Company Secretary. 
 
The new ticker will change to BUD and the ISIN will be GB00BJN5JS53. 
 
Having raised GBP262,742, and disposed of Flamethrower, the Company will now 
focus on its new Investment Strategy to invest in the developing market for 
medicinal or therapeutic Cannabis related products. The Board believes there 
are now an array of quality companies that will obtain regulatory approvals for 
cannabis, medicinal or therapeutic  products, which will bring relief to a 
variety of  symptoms such as pain, nausea, spasticity and other conditions. 
 
Following the Placing and fees for professional services and the consolidation, 
there are now 35,556,549 Ordinary Shares of GBP0.0001 in issue. This figure my be 
used by Shareholders in the Company as the denominator for the calculations by 
which they will determine if they are required to notify their interest in, or 
a change in their interest in, the share capital of the Company under the FCA's 
Disclosure and Transparency Rules. 
 
Application will be made for the 27,502,825 new Ordinary Shares, pursuant to 
the Placing  (17,516,162 Ordinary Shares) and fees for professional service 
(9,986,663 Ordinary Shares), to be admitted to trading on the NEX Exchange 
Growth Market and it is expected that admission will occur on or around 28 June 
2019. 
 
Incoming Non-Executive Director, Burns Singh Tennent-Bhohi stated: 
 
"I would like to extend my gratitude to the shareholders of Valiant and the 
Board of Directors for their support and contribution to this corporate 
restructure. The rationale for creating Eurocann was to provide UK Investors 
and UK capital markets with direct exposure to the medicinal cannabis industry 
through a domestic listing in the UK. It is very much the opinion of the Board 
that advanced economies internationally have identified, researched, and 
understood the health benefits associated with the use of medicinal cannabis, 
whilst the UK market remains fairly limited when considering capital investment 
in the industry. 
 
The international network that we collectively work with are excited at the 
opportunity to invest in these opportunities and specific interest has been 
shown in UK-listed companies undertaking such transactions. The Board and I are 
eager to push-on and look forward to keeping our shareholders informed of 
developments within the business." 
 
Audited Results and Share Suspension 
 
It is expected that the audited financial results to 30 November 2018 will be 
published during the week commencing 24 June 2019. Once the audited results are 
released, the Company will request that the suspension in trading in the 
Company's Ordinary Shares be lifted. 
 
The Directors of Valiant accept responsibility for the contents of this 
announcement. 
 
ENQUIRIES: 
 
Company 
 
Valiant Investments plc 
(To be renamed Eurocann International plc) 
Conrad Windham/ Burns Singh Tennent-Bhohi 
Telephone: 01366 500722 
 
Corporate Adviser 
Peterhouse Capital Limited 
Guy Miller and Mark Anwyl 
Telephone: 020 7220 9796 
 
 
 
END 
 

(END) Dow Jones Newswires

June 24, 2019 02:00 ET (06:00 GMT)